Skip to main content
Clinical Trials/CTRI/2026/01/101775
CTRI/2026/01/101775Not yet recruitingNot Applicable

Evaluating The Role Of Individualized Homoeopathic Treatment Using Homoeopathic Medical Repertory In The Management Of Allergic Rhinitis: A Prospective Interventional Study In Age Group Of 20 – 50 Years.

Parul Institute Of Homoeopathy And Research1 site in 1 country30 target enrollmentStarted: March 2, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1

Study Overview

Brief Summary

This study is a prospective interventional clinical study to evaluate the role of individualized homoeopathic treatment using the Homoeopathic Medical Repertory in the management of allergic rhinitis in individuals aged 20 to 50 years. The study will be conducted at Parul Institute of Homoeopathy and Research Hospital, Vadodara, with a total sample size of 30 patients and a study duration of 4 months. Each patient will receive individualized homoeopathic treatment based on detailed case taking and systematic repertorization using the Homoeopathic Medical Repertory. The primary outcome of the study will be to know the use of Homoeopathic Medical Repertory and secondary outcome will be the assessment of improvement in the severity of allergic rhinitis symptoms before and after treatment through rhinoconjuctivitis quality of life questionnaire.The study aims to evaluate the effectiveness of individualized homoeopathic treatment and the usefulness of the Homoeopathic Medical Repertory as a clinical tool in the management of allergic rhinitis during the study period.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
20.00 Year(s) to 50.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Pre diagnosed cases of allergic rhinitis with raised serum IgE level.
  • Patients of all socio economic status.

Exclusion Criteria

  • Pregnant and lactating women.
  • Patients with gross pathological changes.
  • Patients who are currently taking immunosuppressive therapy.

Investigators

Sponsor
Parul Institute Of Homoeopathy And Research
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Anjali Chauhan

Parul Institute Of Homoeopathy And Research And Hospital

Study Sites (1)

Loading locations...

Similar Trials